Large-scale compatibility assessments between ACE2 proteins and diverse sarbecovirus spikes
Large-scale compatibility assessments between ACE2 proteins and diverse sarbecovirus spikes
批准号:
10722852
负责人:
Kenneth A Matreyek
金额:
$24.15万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-23 至 2025-05-31
关键词:
2019-nCoVACE2AffinityAfricaAmino Acid SequenceAmino AcidsAnimalsArenavirusAsiaBar CodesBindingBiological AssayBiologyBiotechnologyCOVID-19 pandemicCatalogsCell surfaceCellsChiropteraComplexComputer ModelsCoronavirusCoronavirus spike proteinDNA sequencingDataData AnalysesDisease OutbreaksEuropeEventFamilyFilovirusFlow CytometryFutureGeneticGenetic studyGoalsHabitatsHealth systemHigh-Throughput Nucleotide SequencingHumanInfectionIntegration Host FactorsLearningLibrariesLightMachine LearningMammalsMerbecovirusMethodsModelingModernizationMolecularOrganismOrthologous GenePatternPlasmidsPlayPredispositionProbabilityProteinsPublic HealthReceptor CellResearch InfrastructureRoleSamplingSarbecovirusSeriesSevere Acute Respiratory SyndromeTestingTimeTissuesTrainingTravelTropismVariantViralVirusWorkZoonosesbetacoronaviruscellular engineeringcross-species transmissiondata accessdensityexperimental studyfuture pandemicgenetic informationimprovedinsightinterestluminescencemembermutantmutation screeningpandemic diseasepreventreceptorreceptor bindingsynthetic biologytoolviral pandemiczoonotic spillover
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Viral spillover from animal reservoirs into humans can decimate public health systems and cripple the
world economy, as evident with the current SARS-CoV-2 pandemic. Continued wildlife habitat destruction,
human expansion, and routine global travel keep increasing the likelihood that another viral pandemic will
occur again within the next few decades. Beta coronaviruses are an incredibly diverse family of viruses
observed across Asia, Europe, and Africa, that have proven capable of zoonotic spillover into humans as they
have caused multiple worldwide outbreaks over the last two decades. We still lack the fundamental
understanding of the molecular and genetic factors that dictate the molecular compatibilities that determine
which beta coronaviruses are most likely to jump into humans in the future.
The ability of SARS-like beta coronaviruses to utilize ACE2 as a receptor for cell entry is a major factor
determining the extent of coronavirus tropism across species or within the tissues of an organism. While
SARS-CoV-2 has been heavily studied, almost nothing is known about most other members of this virus
family. Traditional studies can only test a handful of conditions at a time, incompletely sampling the vast range
of relevant experimental conditions, particularly for the hundreds of uncharacterized beta coronaviruses. Large-
scale, minimally-biased, cell-based entry assays are needed to model how these factors converge to dictate
the probability of infection.
We will pair new methods in cell engineering and synthetic biology with DNA-sequencing enabled
multiplex genetic assays to perform a series of large-scale infection assays revealing the factors determining
susceptibility to beta coronavirus entry. These large-scale experiments will reveal how ACE2 sequence and
cell surface density impact the efficiency of virus entry. By testing a library of receptor binding domain
sequences identified from ecological surveillance of bat coronaviruses, we will identify which viruses possess
sufficient affinity to human ACE2 to potentiate cross-species transmission, and create a catalog describing all
of the different ways these viruses have evolved their sequences to engage ACE2. By modeling the
relationship between spike and ACE2 protein sequence, expression level, and efficiency of cell entry, we will
identify potential animal reservoirs for SARS-CoV-2 and other SARS-like bat coronaviruses, and predict which
viruses have sufficient binding with human ACE2 to potentially spark the next pandemic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Recombinant DNA technologies for multiplex genetic assays in human cells
-
批准号:10447743
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:Kenneth A Matreyek
-
依托单位:
Recombinant DNA technologies for multiplex genetic assays in human cells
-
批准号:10622541
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:Kenneth A Matreyek
-
依托单位:
Recombinant DNA technologies for multiplex genetic assays in human cells
-
批准号:10275903
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:Kenneth A Matreyek
-
依托单位:
Multiplex discovery of synthetic host-protein combinations that inhibit HIV
-
批准号:10305688
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2020
-
负责人:Kenneth A Matreyek
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: